Knox Lane Invests in HCEsquared

Knox Lane Announces Strategic Investment in Elevation Labs

June 1, 2022

Consumer Products

Knox Lane, a San Francisco-based growth investment firm, has made a strategic growth investment in Elevation Labs, a leading formulator and contract manufacturer of premium beauty products headquartered in Idaho Falls, Idaho. The partnership will support Elevation Labs' expansion of capacity, capabilities and team, and the company plans to pursue strategic acquisitions to complement its organic growth; terms were not disclosed.

Knox Lane Makes Strategic Growth Investment in Spectrum Science

February 1, 2023

Marketing & Advertising

Knox Lane, a San Francisco-based growth investment firm, has made a strategic minority investment in Spectrum Science, an independent healthcare-focused marketing, communications and media firm. The investment will support Spectrum's expansion of strategic communications, clinical trial recruitment capabilities and technology enablement; Jonathan Wilson will remain CEO and serve as an Executive Member of the Board.

Knox Lane Acquires Majority Stake in All Star Healthcare Solutions

May 2, 2024

Healthcare Services

Knox Lane, a growth-oriented investment firm, acquired a majority stake in All Star Healthcare Solutions, a Florida-based locum tenens and healthcare staffing provider. The All Star founders and management will retain a significant minority and reinvest; the partnership will support organic growth, technology investment and strategic acquisitions to scale the business.

Knox Lane Acquires Majority Stake in Elevation Labs from Clearview Capital

July 7, 2022

Manufacturing

Knox Lane announced a strategic majority investment in Elevation Labs (NCL Acquisition Corp. and subsidiaries), acquiring the company from Clearview Capital Fund III. Varagon Capital Partners supported Knox Lane’s investment; Elevation Labs is a contract formulator and manufacturer of premium skincare, haircare and color products with facilities in Idaho Falls, Idaho and Denver, Colorado.

Accelmed Partners Makes $35M Growth Investment in SKNV

November 14, 2022

Healthcare Services

Accelmed Partners completed a $35 million growth investment in SKNV Inc., a Florida-based dermatology digital health company and FDA-registered 503B outsourcing facility that supplies customized medications and an ecommerce/in-practice dispensing platform. Proceeds will fund a new manufacturing facility in Florida, scale SKNV's proprietary digital platform, expand its U.S. sales footprint, and add strategic management hires.

Knox Capital Makes Strategic Growth Investment in Collabtech Group

April 2, 2020

IT Services

Knox Capital Holdings, LLC has made a strategic investment in Collabtech Group to accelerate the collaboration-technology services company’s international expansion and scale its workforce and infrastructure. The capital will support hiring across HR, accounting and sales at Collabtech’s Arizona location as the firm expands its global presence and managed services offering.